Gildead ends remdesivir trial after inconclusive results

Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Heidi Chung discuss the latest market action for Gilead Sciences. …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.